Dana-Farber cancer center deal highlights a surprising trend

Even as more medical care moves outpatient, new cancer centers are in vogue thanks to the advent of CAR-T therapies.

September 19, 2023 Check out STAT+

Sponsored By

Craig F. Walker/The Boston Globe STAT+ | Dana-Farber deal highlights a surprising trend: New cancer centers are in vogue Medical care is moving outpatient, but Dana-Farber is building a new cancer center. Why? CAR-T therapies are delivered in hospitals. By Tara Bannow STAT+ | Dana-Farber blindsided Brigham and Women's. The blowback will be strong Dana-Farber Cancer Institute is ending its long and nationally acclaimed adult oncology partnership with Brigham and Women's Hospital. By Larry Edelman — Boston Globe STAT+ | House subcommittee forays into fixing drug shortages A House subcommittee took a first step today toward legislation to fix drug shortages at hospitals. Don't expect a new law soon, though. By John Wilkerson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser